drugset / Trial / NCT01016561

Magnetic Resonance Imaging-Based Radiation Therapy and Cisplatin in Patients With Stage I, Stage II, Stage III, or Stage IV Cervical Cancer

NCT01016561

NaSingle-groupOpen-labelTreatment

Summary

Rationale: Computer systems that allow doctors to create a 3 dimensional (3-D) picture of the tumor may help in planning radiation therapy and may result in more tumor cells being killed. Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. Drugs, such as cisplatin, may make tumor cells more sensitive to radiation therapy.

Timeline

Start
2009-07
Primary completion
2012-07
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Background Cisplatin Other / unclassified Intravenous

Indications